About The Author
Paul Pruitt is the chief growth officer at SHARx, a prescription drug procurement firm, and the parent of two children who are affected by a disease that is treated with a drug that costs $110,000 per patient per month.
CONNECT WITH THIS AUTHOR
September 09, 2026
